SGSofia Svensson Di Giorgio

Sofia Svensson Di Giorgio

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sofia Svensson Di Giorgio has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Role of ERCP in the Management of Primary Sclerosing Cholangitis: A Review

    by Sofia Svensson Di Giorgio, Valeria Vespasiano, Urban Arnelo, Roberto Valente

    Primary sclerosing cholangitis (PSC) is a chronic inflammatory cholestatic liver disease of unknown aetiology, characterized by the progressive development of strictures involving the intrahepatic and extrahepatic biliary tree, ultimately leading to end-stage liver disease and an increased risk of cholangiocarcinoma. Approximately half of patients with PSC develop multiple biliary strictures over the course of the disease, which may result in infectious complications and obstructive jaundice. Importantly, these strictures may harbour dysplasia or malignancy; however, distinguishing benign inflammatory or fibrotic strictures from malignant lesions remains particularly challenging based on radiological findings alone. Endoscopy, particularly endoscopic retrograde cholangiopancreatography (ERCP), plays a pivotal role in both the diagnostic evaluation and therapeutic management of patients with PSC. In recent years, substantial advances have been made in endoscopic techniques aimed at improving diagnostic accuracy, with peroral cholangioscopy emerging as a particularly promising modality. In this review, we summarize the current role of endoscopic therapy and discuss recent and emerging advances in endoscopic diagnostic strategies for patients with PSC.

  • Open Access

    Primary Sclerosing Cholangitis: Diagnosis, Management, and Clinical Challenges

    by Sofia Svensson Di Giorgio, Chiara Maria Scandavini, Antonio Molinaro, Urban Arnelo, Roberto Valente

    Primary sclerosing cholangitis is a rare, chronic, inflammatory disease of the biliary tree that leads to progressive ductal obliteration, hepatic dysfunction, and ultimately liver cirrhosis. Most patients eventually require liver transplantation or develop serious complications, the most severe being end-stage liver disease and cholangiocarcinoma. The global prevalence of PSC is rising and has been reported to reach up to 31.7 cases per 100,000 individuals, representing a significant challenge in both diagnosis and management. In this review, we aim to provide a clinically oriented overview of the diagnosis and management of PSC. Furthermore, we seek to highlight key challenges and areas of uncertainty that clinicians encounter in the diagnosis and treatment of patients with this complex disease.